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Abstract 
 
Maggots' abilities to aid in treatment of infected and necrotic wounds have been known for 
centuries. Larval therapy (LT) was used frequently in human patients in the first half of the 20th 
century, but usage declined with the introduction of antibiotics. It regained popularity only recently 
due to the emergence of antibiotic resistance. In veterinary patients though, the treatment is still 
rare, and clinical studies are few and of poor quality. The objective of this veterinary nursing under-
graduate project is to assemble relevant literature on larval therapy to form a theoretical foundation 
from which further steps towards clinical use of LT in companion animals can be taken. Currently, 
maggots are used in humans primarily to treat chronic ulcers not responding to conventional 
treatment. Indications for use in small animals include pressure ulcers and traumatic wounds. In 
horses LT is most commonly used to treat different diseases of the hoof. Findings indicate that 
maggots are effective in debridement and disinfection of wounds, as well as promoting granulation 
tissue formation. Maggots are also effective in treating wounds colonised with MRSA. Adverse 
effects are few and infrequent, with pain being the most commonly mentioned. In practice, sterile 
larvae are applied to the wound either freely or contained in a biobag. Dressings are adapted to 
enclose maggots, to be absorbent of heavy exudation while still allowing oxygen to reach the 
maggots and to protect the peri wound skin from wound exudate and larval excretions/secretions. 
For clinical use in the veterinary field, further research is required in several areas, including 
establishing number of maggots needed for safe yet efficient treatment and determining which 
patients are likely to benefit from the therapy. Problems to overcome related to veterinary nursing 
are likely to be difficulties in dressing wounds, prevention and identification of pain and 
overcoming issues with owner acceptance of therapy. 
 
 
Introduction 
 
With the increasing problem of antibiotic resistance in the veterinary field, any alternative treatment 
which may lead to less use of antibiotics deserves further research. Larval therapy can potentially 
not only reduce antibiotic use, but also effectively disinfect wounds already colonised with resistant 
bacteria. The fact that maggot secretory and excretory products are also said to enhance wound 
healing makes the therapy all the more interesting. Additionally, developing LT for use in dogs, cats 
and horses will add one more treatment method to utilise in non-healing wounds before resorting to 
the final treatment option, euthanasia. 
 
 
Larval therapy – a historical perspective 
Maggots’ favourable effects in wounds have been recognised since the 16th century (Goldstein, 
1931). According to Goldstein (1931), the idea of purposefully breeding maggots for use in wound 
care was born in early 20th century. Several military surgeons observed the beneficial effect maggots 
of the green blowfly Lucilia sericata had on wounds during World War I (Baer, 1931; Goldstein, 
1931). Treating two soldiers with compound fractures and large flesh wounds filled with maggots 
led one surgeon to believe that maggots could be of use in the prevention and curing of infection 
(Baer, 1931). The soldiers had been lying on the battlefield for a week with no access to food or 
water, yet they presented no fever and no evidence of septicaemia, and underneath the maggots their 
wounds had begun to heal. Baer (1931) later performed the first experimental voluntary use of 
maggots in wound care, and went on to treat several cases of osteomyelitis successfully. 
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Larval therapy (UK), or maggot debridement therapy (US), gained popularity in human medicine 
and was frequently used in hospitals in the first half of the 20th century, but fell out of favour when 
antibiotics were introduced (Courtenay et al., 2000). LT made a comeback in the 1980s with the 
increasing occurrence of antibiotic resistance and since then improved methods using sterile larvae 
have been developed (Beasley & Hirst, 2004). In work animals, maggots have been used in folk 
medicine in treating infected wounds caused by chafing work equipment (Dar et al., 2013). Early 
reports in literature include potential use in the buffalo (Iversen, 1996), and the successful treatment 
of wounds not responding to conventional treatment in a donkey (Bell & Thomas, 2001). The use of 
maggots in companion animal wound care is still rare, but as antibiotic resistance is an issue in 
veterinary medicine as well, larval therapy is a treatment option for dogs, cats and horses that is 
worthy of more attention (Jones & Wall, 2007). 
 
 
Antibiotic resistance 
Resistance has developed due to several factors, one of the most important being the use and misuse 
of antibiotics (Boothe, 2006; EWMA, 2006). Acquired antimicrobial resistance is a significant 
problem in veterinary medicine (Loeffler et al. 2009; Weese & van Dujikeren, 2009), as well as a 
health risk for personnel due to the risk of zoonotic transmission (O'Mahony et al., 2005; Loeffler et 
al. 2009; Weese & van Dujikeren, 2009). 
 
Methicillin-resistant Staphylococcus aureus  (MRSA) and Methicillin-resistant Staphylococcus 
pseudintermedius (MRSP) are resistant to a broad range of important antimicrobials including 
penicillins, cephalosporins and carbapenems (Weese & van Dujikeren, 2009). S. aureus is the most 
commonly occurring bacteria in human wounds (Bexfield et al., 2004; Bexfield et al., 2008). In 
1961, less than two years after the introduction of methicillin, S. aureus first acquired resistance it 
(Bexfield et al., 2004). In Sweden, MRSA was first confirmed in animals by SVA, the National 
Veterinary Institute, in 2006 (SVA, 2012). Between 2006 and 2011, a total of 45 cases were verified 
at SVA; 18 dogs, 5 cats and 17 horses. In other countries, MRSA can be found in 0-4% of healthy 
dogs and cats, in 9% of hospitalised dogs and in 0-10,9% of horses in various populations (Weese & 
van Dujikeren, 2009). There is a high prevalence of MRSA carriage, 7,5-12,3%, in veterinary staff 
and among pet owners in the UK (Loeffler et al. 2009). S. pseudintermedius is a part of the normal 
microflora of dogs and cats (Weese & van Dujikeren, 2009). The first case of MRSP verified in 
Sweden was in a healthy dog, screening for MRSA in 2006 (SVA, 2012). In 2011, 60 cases were 
confirmed by SVA; 59 dogs and one cat. Since 2006, MRSP has only been verified in two horses in 
Sweden. Internationally, MRSP carriage is 2-30% in hospitalised cats and dogs compared to 1,5-4% 
in healthy populations (Weese & van Dujikeren, 2009). Although MRSP has been isolated from 
humans, Weese & van Dujikeren (2009) conclude that it is uncommon even in individuals with 
frequent animal contact, making it a less important zoonotic pathogen than MRSA. 
 
To prevent further spread of antibiotic resistance strategies include appropriate use of antimicrobials 
(Boothe, 2006; SVA, 2012) Antibiotic use should be limited to treatment of systemic infections and 
directed towards susceptible organisms, confirmed by cultures (EWMA, 2006; Hollis, 2011). 
Further strategies include implementation of hygiene routines (Boothe, 2006; SVA, 2012) and 
decrease length of hospital stay (Boothe, 2006). 
 
 
Management of infected wounds 
It is important to understand the phases of wound healing to effectively manage wounds (Chivers, 
2010; O'Dwyer, 2012). Wound healing can be divided into three phases: the inflammatory phase, 
the proliferative phase and the remodelling phase (Hosgood, 2006). Inflammation is important in 
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the healing process (Guo & DiPietro, 2010; Hollis, 2011). In the inflammatory phase leucocytes 
migrate into the wound; neutrophils remove bacteria and debris from the wound by phagocytosis 
and monocytes become wound macrophages that debride necrotic tissue, reducing bacteria and 
organic debris (Hosgood, 2006; Hollis, 2011). Proteolytic enzymes break down proteins into a 
liquid form that can be easily digested by macrophages (Hollis, 2011). As macrophages increase in 
numbers, debridement begins, marking the transition into the proliferative phase (Hosgood, 2006). 
In the proliferative phase new capillaries, fibroblasts and fibrous connective tissue become 
granulation tissue, which protects the wound, provides a barrier to infection and provides a surface 
for epithelisation, according to Hosgood (2006). The article explains that wound contraction is also 
a part of the proliferative phase; the wound reduces in size in response to fibroblastic invasion and 
changes in the tension of the wound and surrounding tissue. Wound contraction continues until the 
wound edges meet and the remodelling phase is initiated; connective tissue is remodelled and 
collagen bundles are rearranged to form a scar, as described by Hosgood (2006). 
 
The three phases are not always distinct; they can overlap as one phase leads on to the next 
(Chivers, 2012). If the wound is infected for instance, inflammation may be prolonged, making it 
difficult to determine the age of the wound (Hosgood, 2006; Guo & DiPietro, 2010). Failure in any 
phase will result in delayed healing, which if uncorrected will result in chronic non-healing wounds 
(O'Dwyer, 2012). Two of the most common factors resulting in delayed wound healing are infection 
(EWMA, 2006; Hosgood, 2006; Hollis, 2011; O'Dwyer, 2012) and necrotic tissue (O'Dwyer, 2012). 
 
Infection inhibits all stages of wound healing (Hosgood, 2006); infected wounds always heal slower 
than non-infected wounds (O'Dwyer, 2012). Bacteria are the likely cause in most wound infections, 
but infection can also be caused by fungi, yeasts or viruses (Hollis, 2011). All wounds contain 
bacteria (EWMA, 2006; Hollis, 2011), but a wound is only acknowledged as infected when a 
reaction is initiated in the host (Hollis, 2011). Bacteria in infected wounds occur in the form of 
biofilms on the surface; a biofilm can act as a barrier preventing antibiotics from penetrating the 
wound (Guo & DiPietro, 2010; O'Dwyer, 2012). As biofilms mature, they become more resistant, 
possibly explaining why many chronic ulcers do not respond to antibiotic treatment (Guo & 
DiPietro, 2010). Aside from delayed wound healing, signs of infection include increased exudate 
with changed appearance, an unusual smell (Ramundo & Wells, 2000; Hollis, 2011), erythema, 
warmth and pain or tenderness (Ramundo & Wells, 2000).  
 
Wound management strategies aim to accomplish wound healing rapidly by creating optimal 
healing conditions (EWMA, 2006). The wound is initially assessed; aetiology and level of 
contamination serve as indicators of required management and provide of a prognosis with expected 
length of treatment (Chivers, 2010; Hollis, 2011). To manage an infected wound, reduction of 
microbial load is of utmost importance (Ramundo & Wells, 2000; Hollis, 2011). Antibiotics alone 
will not achieve this, thus not removing the initial cause for infection (Hollis, 2011). Basic wound 
management techniques such as lavage and debridement are important in reducing bacterial load 
and thereby preventing establishment of biofilms (Hosgood, 2006; Hollis, 2011; O'Dwyer, 2012). 
Topical antimicrobials, including honey, iodine, silver and clorhexidine, can also be used to reduce 
bioburden (EWMA, 2006). The European Wound Management Association, EWMA (2006), 
recommends that antimicrobial agents must be used with caution to remain effective, as resistance 
to topical agents such as silver and iodine has been reported. EWMA (2006) recognises larval 
therapy as an alternative method of reducing microbial load that is not susceptible to resistance. 
 
Debridement, removal of necrotic tissue, is thought to be one of the most important steps in wound 
management (Ramundo & Wells, 2000; Wolff & Hansson, 2003); especially in treatment of chronic 
wounds (Wollina et al., 2002). Debridement can be surgical, chemical or autolytic (Ramundo & 
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Wells, 2000; Chivers, 2010). In autolytic debridement, the wound is rehydrated using special 
dressing materials (Ramundo & Wells, 2000). Although the most selective method, it is slow and 
sometimes insufficient (Wolff & Hansson, 2003). Surgical debridement is faster and more effective, 
but painful and less selective as healthy tissue can be mistakenly resected (Ramundo & Wells, 2000; 
Wolff & Hansson, 2003). Chemical, or enzymatic, debridement is slower than surgical, but involves 
less pain and no loss of viable tissue (Ramundo & Wells, 2000). The use of maggots rates as 
chemical debridement, but is often referred to as biological debridement or biosurgery according to 
Ramundo & Wells (2000). The debridement process should be initiated by a physician, but the 
procedures, with the exception of surgical debridement, are generally performed by nurses 
(Ramundo & Wells, 2000; Chivers, 2010). Regardless of therapy chosen, the wound must be 
continuously reassessed, and the strategies reevaluated if the wound does not change for the better 
(EWMA, 2006). When bioburden has been reduced, healing becomes the goal of wound care 
(Ramundo & Wells, 2000). 
 
 
Objective 
 
The objective of this undergraduate examination project is to review the scientific evidence for 
larval therapy, to determine its potential usefulness in veterinary wound care, by answering the 
following questions: 
 Is LT an appropriate treatment method for companion animals? 
 Which mechanisms make maggots of beneficial in wound care?  
 How is LT carried out in practice? 
 Which veterinary nursing aspects are there of treating patients with LT? 
The information will be assembled into a comprehensive student report that will hopefully raise 
interest in the use of maggots in companion animal wound care, as well as describe the basics of 
larval therapy for those interested in practicing it clinically. 
 
 
Materials and method 
 
This literature study was performed by searching for literature using different combinations of the 
search words maggot, larvae, Lucilia sericata, nursing, debridement, treatment, therapy, wound, 
healing, infection, biosurgery and antimicrobial. The search was initially narrowed by adding the 
words canine, dog, feline, cat, equine, horse, veterinary or small animal, but as very little material 
was found, the search was extended to cover human literature as well. The search covering human 
literature generated numerous results. To utilise the most recent research, articles used were limited 
to those published after the year 2000. Articles were found primarily through the search engine 
Google Scholar and by researching citations in relevant literature. 
 
A total of 41 pieces of literature were used in this overview, not counting the 12 references used 
exclusively in the introduction. To achieve the result 33 texts were studied, of which a majority of 
25 were original articles. Three review articles of veterinary origin were included due to shortage of 
clinical trials in the veterinary field. Two additional reviews were used as an alternative to original 
articles, to limit the extent of the work; one dealing with management of wound infection in humans 
and one compiling information on maggots’ effect on MRSA. Though not peer reviewed, one 
scientific book describing human wound care nursing and two veterinary nursing articles focusing 
on infected wounds were included to obtain information on basic nursing needs. An additional eight 
references were used in the discussion; six of which were original articles. 
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Result 
 
Patient treatment options 
The main indication for larval therapy in human patients is infected wounds with slough or necrotic 
tissue (Courtenay et al., 2000; Steenvoorde et al., 2007). It is used to treat chronic non-healing 
wounds (Ramundo & Wells, 2000; Steenvoorde et al., 2007); ulcers (Wolff & Hansson, 2003; 
Bowling et al., 2007) such as pressure ulcers and vascular ulcers are the primary cause of treatment 
(Courtenay et al., 2000; Wollina et al., 2002; Steenvoorde et al., 2007). LT can also be used to treat 
wounds colonised with MRSA (Bowling et al., 2007). Underlying cause for treatment in human 
medicine includes trauma (Steenvoorde & Jukema, 2004; Steenvoorde et al., 2007), diabetes 
mellitus (Steenvoorde & Jukema, 2004; Bowling et al., 2007; Steenvoorde et al., 2007) and 
vascular insufficiency (Steenvoorde & Jukema, 2004). 
 
In companion animals, LT has been used to assist in healing of chronic wounds where conventional 
therapies have failed, to effect debridement and to control infection (Sherman et al., 2007a; 
Sherman et al., 2007b). Durations and sizes of wounds prior to therapy vary in veterinary studies 
(Tab. 1). In small animals, wounds have been located to limbs (Kočišová et al., 2003; Sherman et 
al., 2007b), paws, back and perineum (Sherman et al., 2007b). Wound aetiology includes pressure 
ulcers such as bedsores (Kočišová et al., 2003; Sherman et al., 2007b) and traumatic wounds, such 
as bite and scratch wounds (Sherman et al., 2007b). In horses, treatment of diseases in the foot such 
as abscesses (Sherman et al., 2007a), septic navicular bursitis (Lepage et al., 2012), chronic 
laminitis (Sherman et al., 2007a; Morrison, 2007) and coffin bone osteomyelitis appears to be most 
common (Morrison, 2007). Other treated podiatric conditions include chronic distal interphalangeal 
joint sepsis, canker, acute caudal coffin bone rotation, non-healing foot ulcers and necrosis of 
collateral cartilage (Morrison, 2007). Additionally, treatments of traumatic wounds, chronic ulcers 
(Sherman et al., 2007a), soft tissue abscesses and MRSA infected wounds are reported in horses 
(Lepage et al., 2012). 
 
Table 1: wound characteristics prior to treatment in companion animals receiving LT 
Patients Duration of wound, days Size of wound, cm² Reference 
Species Number Average Range Average Range Author(s), 
year 
Equids (horses, 
ponies, donkeys) 
41 (35, 2, 4) - 2-56 - - Lepage et al., 
2012 
Horses 13 36 2-90 - 10-1800 Sherman et al., 
2007a 
Small animals 
(dogs, cats, rabbit) 
7 (2, 3, 1) 28 4-119 28 2-63 Sherman et al., 
2007b 
 
Patients with rapidly advancing infection (Jones & Wall, 2007) and sepsis should not initially be 
treated with larval therapy (Steenvoorde et al., 2007). Other contraindications include wounds 
where maggots may become irretrievable (Beasley & Hirst, 2004); this includes fistulae (Jones & 
Wall, 2007; Dar et al., 2013), wounds that may connect with body cavities or sinuses (Beasley & 
Hirst, 2004; Jones & Wall, 2007; Dar et al., 2013), and wounds close to the brain (Courtenay, 
2000). Maggots abrading small blood vessels can cause bleeding (Jones & Wall, 2007), making 
wound proximity to large vessels a contraindication (Courtenay, 2000; Jones & Wall, 2007; Dar et 
al., 2013). Heavily exudative (Jones & Wall, 2007) or hemorrhagic wounds will cause maggots to 
drown (Jones & Wall, 2007; Dar et al., 2013), or at the very least cause dilution of the maggots 
proteolytic enzymes, resulting in ineffective therapy (Jones & Wall, 2007). Dry necrotic wounds are 
not suitable for LT either, as maggots may dry out (Jones & Wall, 2007; Dar et al., 2013).  
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Results of larval therapy in clinical studies 
In human patients, debridement by maggots has been found to be very effective; both fast and 
precise (Wollina et al., 2002; Wolff & Hansson, 2003). In one study, 43% (n=70) of wounds were 
debrided fully and 29% partially after the treatment period; area of necrotic tissue was reduced by 
an average of 68% (Courtenay et al., 2000). In other studies, 100% (n=13) of wounds were fully 
debrided (Bowling et al., 2007), and 80% (n=74) of wounds were ultimately debrided by 66-100% 
(Wolff & Hansson, 2003). Other results of LT in humans include improved granulation and wound 
healing (Wollina et al., 2002). An average wound size reduction of 5% and granulation tissue 
increase of 26% has been reported (Courtenay et al., 2000). Granulation tissue increased in all 
patients (n=13) in a study of wounds colonised with MRSA (Bowling et al., 2007). In the study, 
maggots successfully removed infection in an average of three weeks, without MRSA specific 
antibiotic treatment. Compared to the average duration of conventional MRSA treatment, reported 
as 28 weeks, Bowling et al. (2007) conclude that LT appears to be a superior alternative. Malodour 
was also reduced in 81% (n=70) (Courtenay et al., 2000) and 58% (n=31) of the wounds (Wolff & 
Hansson, 2003). Furthermore, no patients required antibiotic treatment after completion of LT in 
one of the studies (Courtenay et al., 2000). 
 
Maggots accomplish successful debridement of necrotic wounds (Kočišová et al., 2003; Sherman et 
al., 2007b; Lepage et al., 2012) and treatment of infection in companion animals as well (Morrison, 
2007). Promotion of granulation tissue formation is also seen in animals, and has been observed in 
studies after three days of treatment (Kočišová et al., 2003; Lepage et al., 2012). Although LT was 
found successful, treatments such as surgery, casting and special shoeing were crucial for a positive 
outcome in horses (Morrison, 2007). Also, light surgical debridement was performed prior to LT in 
many equine cases to remove debris and dry necrotic tissue (Morrison, 2007; Lepage et al., 2012). 
The therapy appeared to be well tolerated by patients (Kočišová et al., 2003). 
 
In studies of small animals and horses receiving LT, patient outcomes range from full recovery to 
euthanasia (Tab. 2). Prior to treatment, euthanasia or death was the expected outcome in five small 
animal patients (n=7) (Sherman et al., 2007b) and six horses (n=13) (Sherman et al., 2007a). Two 
small animals were expected to require amputation; in one of these patients the limb was ultimately 
saved after LT (Sherman et al., 2007b). Death or euthanasia was due to severity of pre-existing 
diseases, and was not associated with treatment failure (Morrison, 2007; Sherman et al., 2007b). 
 
Table 2: Results of larval therapy in companion animals 
Patients Result Reference 
Species Number Full recovery Complete healing, but inability 
to return to intended use 
Incomplete 
healing 
Death or 
euthanasia 
Author(s), 
year 
Rabbits 3 100% - - - Kočišová et 
al., 2003 
Equids (horses, 
ponies, donkeys) 
41 (35, 2, 
4) 
93% - 5% 2% Lepage et al., 
2012 
Horses 108 68% 11% - 21% Morrison, 
2007 
Horses 13 46% 38% 8% 8% Sherman et 
al., 2007a 
Small animals 
(dogs, cats, rabbit) 
7 (2, 3, 1) 57% - 14% 28% Sherman et 
al., 2007b 
 
Pain is the most commonly mentioned side effect in humans (Tab. 3). Most human patients 
experienced mild pain (Wollina et al., 2002; Courtenay et al., 2000), severe pain was only reported 
in one study, in 9% (n=70) of the patients (Courtenay et al., 2000). The pain was considered 
temporary (Wollina et al., 2002) and usually appeared 2-3 days after initiation of therapy 
(Courtenay et al., 2000). Pain may be ascribed to the use of free range maggots, as in one study 
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none of the patients treated with the biobag technique experienced any pain (Steenvoorde & 
Jukema, 2004). Other possible explanations are changes in wound pH or the sensation of maggots 
crawling in the wound (Jones & Wall, 2007). It should be noted that during treatment in two studies 
25% (n=61) (Wolff & Hansson, 2003) and 69% (n=70) of patients experienced less pain than before 
(Courtenay et al., 2000). Other adverse effects of larval therapy reported in humans (Tab. 3) are rare 
and normally uncomplicated (Beasley & Hirst, 2004). 
 
Table 3: adverse effects experienced during larval therapy 
Patients Adverse effects Reference 
Species Number Pain Discom-
fort 
Bleeding Pyrexia or 
influensa-like 
symptoms 
Maggot 
related 
anxiety 
Author(s), 
year 
Humans 13 - - - - - Bowling et al., 
2007 
Humans 70 33%  34% 16% - Courtenay et 
al., 2000 
Equids (horses, 
ponies, donkeys) 
41 (35, 2, 
4) 
- 17% - - - Lepage et al., 
2012 
Small animals 
(dogs, cats, rabbit) 
7 (2, 3, 1) - - - - - Sherman et al., 
2007b 
Humans 16 19% - - - - Steenvoorde & 
Jukema, 2004 
Humans 61 34 % - - - 5% Wolff & 
Hansson, 2003 
Humans 30 40% - - - - Wollina et al., 
2002 
 
In horses, discomfort has been reported as the most common adverse effect (Tab. 3) of larval 
therapy (Morrison, 2007; Sherman 2007a) affecting animals 2-3 days into the treatment (Lepage et 
al., 2012). This can be demonstrated by moving or stomping the limb and repeatedly rubbing the 
bandage (Morrison, 2010; Lepage et al., 2012). No adverse effects have been identified in small 
animals (Tab. 3). 
 
 
Mechanisms of biosurgery 
Biosurgery is the procedure in which maggots are applied to necrotic or sloughy wounds to perform 
debridement (Horobin et al., 2005). Maggots of the green bottle fly Lucilia sericata are the most 
preferable for larval therapy; they are necrophagus (Wolff & Hansson, 2005) and feed relatively 
superficially (Jones & Wall, 2007). The species is common in Europe and North America (Wolff & 
Hansson, 2005). Maggots enhance wound healing in three ways; by debriding necrotic tissue, 
promoting granulation tissue formation and helping to disinfect the wound (Horobin et al., 2005). 
 
Debridement 
Lacking teeth, the maggots have a pair of mouth-hooks they use to break down their food source 
(Beasley & Hirst, 2004; Jones & Wall, 2007). The maggots secrete proteolytic enzymes that 
dissolve necrotic tissue from the wound surface, making it into a fluid suitable for ingestion 
(Chambers et al., 2003). The liquefied food is then sucked into their alimentary tract via their 
powerful pharynx (Jones & Wall, 2007). Proteolytic enzymes in secretions are mainly serine 
proteinases of two different subclasses; trypsin-like and chymotrypsin-like proteinases (Chambers 
et al., 2003). The maggots ingest necrotic tissue on a microscopic scale, and they cause minimal 
disruption to viable tissue (Beasley & Hirst, 2004). 
 
Disinfection 
According to previous theories, animals respond to movement and irritation of maggots by 
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producing large quantities of serous exudate, promoting continuous wound lavage and dilution of 
bacterial concentration (Beasley & Hirst, 2004; Jones & Wall, 2007). However, more recent studies 
suggest that the mechanical crawling effect is of very little importance (Blake et al., 2007). 
Disinfection of the wound is now thought to be achieved in two ways; by destruction of bacteria 
through ingestion and by secretion of antibacterial compounds (Beasley & Hirst, 2004). 
 
Antibacterial substances are continuously being produced in the maggots’ saliva; following 
ingestion, bacteria are killed as they pass through the digestive tract (Jones & Wall, 2007). This has 
been determined by feeding green fluorescent protein-producing Escherichia coli to sterile 
maggots; most of the bacteria were destroyed in the anterior part of the hindgut, and close to the 
anus there were practically no viable bacteria left (Mumcuoglu et al., 2001). 
 
Secretions of sterile larvae exhibit antibacterial activity against a range of bacteria (Kerridge et al., 
2005). Growth of Gram-positive bacteria has been shown by Kerridge et al. (2005) to be inhibited, 
whereas growth of Gram-negative bacteria is only slowed down. The antibacterial mechanism has 
been identified as a defensin called lucifensin, which is active in vitro against G+ bacterial strains, 
but not against G- bacteria (Andersen et al., 2010). Similar results were found by analysing wound 
cultures prior to and after maggot treatment in a clinical study (Steenvoorde & Jukema, 2004). The 
analysis indicated that larval removal of G+ bacteria was more efficient than that of G-. However, in 
another study growth of both G+ and G- bacteria were inhibited by antibacterial factors in the larval 
excretions/secretions (ES) (Bexfield et al., 2004). Larval ES exhibits significant antibacterial 
activity against a range of clinically relevant MRSA strains (Bexfield et al., 2004; Kerridge et al., 
2005; Bexfield et al., 2008). This is also reflected in a clinical study, where MRSA colonisation was 
eliminated in 92% (n=13) of human chronic diabetic foot ulcers (Bowling et al., 2007). 
 
Further antibacterial actions include alkalinising wounds through maggots’ excretions of ammonia 
(Chambers et al., 2003; Arora et al., 2011), allantoin and urea (Jones & Wall, 2007), making the 
wound an unsuitable environment for many bacterial species (Arora et al., 2011). The pH of larval 
ES is high (Chambers et al., 2003; Arora et al., 2011), in the range of 8,6-8,7 (Arora et al., 2011). 
Rising pH is also said to provide optimal conditions for proteolytic enzyme activity (Chambers et 
al., 2003). 
 
Promotion of granulation tissue formation 
A possible mechanism by which granulation tissue formation is enhanced has been found by 
investigating the effects of L. sericata ES products on behaviour of fibroblasts; ES significantly 
reduced fibroblast adhesion and promoted spreading across protein surfaces, while keeping cells 
viable (Horobin et al., 2003). Results were verified in a later study, where it was found that 
fibroblast motility was promoted, resulting in a wider distribution of viable fibroblasts in a chronic 
wound (Horobin et al., 2005). Chymotrypsin-like serine proteinases in larval secretions can, in 
addition to removing necrotic tissue, also promote wound healing by aiding in the remodelling of 
provisional extra cellular matrix to granulation tissue (Chambers et al., 2003; Horobin et al., 2003). 
It has also been suggested that secretions of substances such as allantoin, create an optimal 
environment for wound healing (Beasley & Hirst, 2004). 
 
 
Larval therapy in practice 
 
Number of maggots required 
Current recommendation in human medicine is 5-10 maggots per cm² of wound base (Wolff & 
Hansson, 2003; Bowling et al., 2007; Jones & Wall, 2007). In veterinary medicine, use of 5-10 
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(Sherman et al., 2007a; Lepage et al., 2012) and 8-12 maggots/cm² has been reported (Kočišová et 
al., 2003). The number of maggots needed depends on amount of necrotic tissue (Jones & Wall, 
2007). A standard dose of 100 maggots can debride 50 grams of necrotic tissue during one treatment 
cycle, when taking larval death in the wound into account (Blake et al., 2007). Wound depth may 
also need to be considered; when the wound was deeper than 2 cm, the surface area was multiplied 
by the depth of the wound in a study on equids (Lepage et al., 2012). As larval removal of Gram-
negative bacteria appears less efficient (Steenvoorde & Jukema, 2004), a greater number of 
maggots might be required for a wound infected with G- bacteria (EWMA, 2006). Ordering more 
maggots than estimated may need to be considered, as for example only half of the maggots were 
alive and able to debride on delivery after a two day transport (Lepage et al., 2012). It is also more 
cost effective to apply a large number of maggots for a short period of time, rather than small 
number for more extended period (Jones & Wall, 2007). More exact predictions of number of 
maggots needed will lead to economical use, which is of increasing importance (Blake et al., 2007). 
 
Sterile maggots are prepared in a laboratory, where eggs from L. sericata flies are collected and 
sterilised by being rinsed several times in chloramine solution 0, 25% (Wolff & Hansson, 2005). 
Eggs are placed in a transportation flask where the larvae hatch during the first day; the flasks are 
stored at room temperature whilst waiting for results of a disinfection control. As claimed by Wolff 
& Hansson (2005), larvae are always microbiologically tested before use, to certify that no infection 
will be induced by larval therapy. The number of maggots needed for therapy are estimated and 
ordered (Lepage et al., 2012). In Sweden, larvae are distributed by Sahlgrenska University Hospital, 
department of dermatology (Wolff & Hansson, 2005). The maggots are shipped in a temperature 
controlled package (Dar et al., 2013). When the maggots arrive they are approximately one day old 
(Wolff & Hansson, 2003). They should be used as soon as possible, but if necessary maturation can 
be delayed by storing in a refrigerator at 4-8° for two (Blake et al., 2007; Dar et al., 2013) to five 
days (Wolff & Hansson, 2005).  
 
Application techniques; biobag or free range 
There are two methods of larval application (Steenvoorde & Jukema, 2004; Jones & Wall, 2007). In 
the direct contact technique maggots are put freely in the wound, in direct contact with the wound 
surface (Steenvoorde & Jukema, 2004). Alternatively, maggots can be placed in a heat-sealed 
biobag, a small porous bag made of nylon mesh (Jones & Wall, 2007) or polyvinylalcohol 
(Steenvoorde & Jukema, 2004). The structure of the mesh enables the proteolytic secretions to 
reach the necrotic tissue, and maggots can still aid in debridement (Jones & Wall, 2007). 
 
Application of maggots in a biobag is less complicated; it requires less experience and can be 
performed by a single nurse, saving time and resources during dressing changes (Blake et al., 
2007). Another advantage is that treatment using the biobag has been perceived as less painful than 
free range maggots by human patients (Steenvoorde & Jukema, 2004).The biobag may be more 
preferable if the owner of the animal is unwilling to accept the use of maggots in veterinary wound 
care (Jones & Wall, 2007). A study investigating patient acceptability shows that human patients 
would consider maggots in a biobag as an equal alternative to autolytic debridement using a 
hydrogel (Petherick et al. 2006). However, treatment would need to be a mean of three weeks 
shorter than autolytic debridement for patients participating in the study to consider LT with free 
range maggots. According to the findings of another study, a majority of patients with leg ulcers 
would consider the use of larval therapy, regardless of method used (Spilsbury et al., 2008). The 
participants refusing larval therapy were also distributed equally between the two application 
methods. 
 
One disadvantage of the biobag is that maggot debridement is only effective in its direct vicinity, 
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making the biobag ineffective in irregularly shaped wounds (Blake et al., 2007). It can still be used 
according to Blake et al., (2007), although one cycle of free range maggots may be needed. It has 
been described as likely that debridement is less effective as the maggots cannot use mouth hooks 
through the biobag (Jones & Wall, 2007). Use of the biobag has been found to be one of the factors 
that have a significant negative impact on successful outcome of LT (Steenvoorde et al., 2007). In 
contrast, another study comparing the two techniques reveals that debridement efficiency appears to 
be similar (Blake et al., 2007). Statistical analysis revealed no difference between the use of freely 
crawling maggots and maggots in a biobag regarding total amount of debrided tissue after 3 or 4 
days of treatment. 
 
Dressing a wound for larval therapy 
Although wound dressings used in larval therapy differ depending on location of the wound, some 
principles need to be followed for treatment to be successful (Sherman et al., 2007b; Dar et al., 
2013). Both studies recount that dressings must be permeable; maggots are 
oxygen-dependent, so air must be allowed to reach the maggots. A drain can be 
placed to ensure a constant open entrance for the larvae to be sufficiently supplied 
with oxygen in deep, closed or heavily exuding wounds (Jones & Wall, 2007; 
Morrison, 2007). In necrotic cavities an opening can be created to ensure 
drainage and oxygen supply (Dar et al., 2013). Exudate and liquefied necrotic 
tissue must be able to drain freely out of the wound (Sherman et al., 2007b; Dar 
et al., 2013). The surrounding healthy skin must be protected as well (Jones & 
Wall, 2007; Dar et al., 2013). The skin must be protected from maceration due to 
excessive exudation and from damage to healthy tissue caused by proteolytic 
enzymes secreted by larvae; preventing the maggots from crawling on healthy 
skin may also lessen the feeling of discomfort experienced by the patient 
(Ramundo & Wells, 2000). 
 
To prepare for larval therapy, a wide area around the wound is clipped (Sherman 
et al., 2007b; Chivers, 2010), with a sterile water soluble jelly applied in the 
wound to prevent hair contamination (Chivers, 2010; Dar et al., 2013). Non-
sterile single use gloves are worn at all times during wound management 
(Chivers, 2010). Prior to placing maggots, the wound is cleaned with 0, 9% 
saline to remove any topical wound agents (Dar et al., 2013). The patient is 
protected from lavage fluid with incontinence sheets (Chivers, 2010). Special 
care should be taken in the lavage process when products including propylene 
glycol have been used, since it can negatively affect maggot viability (Dar et al., 
2013). In horses, if acrylic or urethane is used in the gluing process of a shoe 
application, at least 24 hours need to pass before larval application, as vapours 
from adhesives can be fatal to maggots (Morrison, 2010). The surrounding 
healthy skin is cleaned, dried and disinfected (Dar et al., 2013). The wound is 
traced on a sheet of sterile plastic (Fig. 1). This is used to help in calculating a 
more exact number of maggots needed for therapy (Jones & Wall, 2007).  
The most common way to dress a wound for larval therapy is a cage like 
dressing (Jones & Wall, 2007; Dar et al., 2013). The primary layer in direct 
contact with the wound (Chivers, 2010) is formed by a hydrocolloid dressing 
with a hole cut in the shape of the wound; the shape is taken from the plastic 
sheet used to calculate number of maggots (Fig. 2). The hydrocolloid dressing 
protects surrounding skin as well as provides a base on which additional 
dressings can be securely fixed (Jones & Wall, 2007; Dar et al., 2013). It also 
serves to relieve pressure to prevent crushing of the maggots (Bowling et al., 
Figure 1: tracing the 
wound on a plastic 
sheet 
Illustration: 
Berglund, C., 2013 
Figure 2: cutting a 
hole in a hydrocolloid 
dressing  
Illustration: 
Berglund, C., 2013 
 
Figure 3: placing 
free range maggots 
in the wound, and 
covering with a net 
Illustration: 
Berglund, C., 2013 
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2007). A deeper wound can be created by using an additional layer of 
hydrocolloid dressing in areas exposed to pressure (Wolff & Hansson, 2003). 
Free range maggots are placed in the wound and covered by a porous sheet or net 
(Fig. 3). The net is fixed securely to the hydrocolloid frame using a waterproof 
adhesive, creating a cage with the maggots inside (Dar et al., 2013). Alternatively, a biobag is 
inserted and fastened to the primary hydrocolloid dressing (Jones & Wall, 2007; 
Sherman et al., 2007b). This is subsequently covered with a secondary layer; an 
absorbent dressing, such as a gauze pad (Fig. 4), to absorb necrotic drainage 
(Jones & Wall, 2007; Sherman et al., 2007b; Chivers, 2010). 
 
Maggot dressings are individually adapted in veterinary medicine (Sherman et 
al., 2007b; Lepage et al., 2012). Different dressings for horses, depending on location of the wound, 
have been described (Morrison, 2010; Lepage et al., 2012). For treatment in the hoof, a temporary 
non-occlusive bandage (Lepage et al., 2012) or full foot cast can be applied; if a cast is used, a 
window is cut in the cast to enable maggots to be placed inside (Morrison, 2010). Wounds located 
to difficult positions on the body or upper limbs can be treated by fastening a biobag to the skin 
with sutures (Sherman et al., 2007a; Lepage et al., 2012). In lower limbs, elastic adhesive bandages 
can be placed proximal and distal to the wound (Lepage et al., 2012). A net is placed around the 
limb, taped down on either side of the wound, and sealed to the lower bandage, as described by 
Lepage et al. (2012). The maggots are then poured into the sleeve created by the net, and the net is 
fixed to the top bandage. 
 
The absorbing layer of the dressing gets soiled quickly as maggot debrided wounds are heavily 
exudative (EWMA, 2006). The outer dressing is changed daily in clinical studies (Morrison, 2010; 
Lepage et al., 2012). The top layers may need to be lifted twice daily to sufficiently aerate the 
maggots (Wolff & Hansson, 2003). To prevent maggots drying out, the maggots can be watered by 
applying fresh gauze moistened with saline over the net after the first day of treatment (Wolff & 
Hansson, 2003; Dar et al., 2013).  
 
Table 4: Length of maggot application cycles in studies 
The maggots are removed from the wound when 
they are fully grown (Wolff & Hansson, 2003; Dar 
et al., 2013). The maggots are typically 1-3 mm long 
when they are applied to the wound (Jones & Wall, 
2007), and 10 mm long when they are removed 
(Wolff & Hansson, 2003). In nature, fully grown 
maggots would leave the wound to pupate in the 
surrounding environment (Jones & Wall, 2007). The 
outer dressings are detached (Jones & Wall, 2007), 
while the hydrocolloid frame may be left in place 
(Dar et al., 2013). Free range maggots are removed 
by hand or using forceps (Dar et al., 2013). Any 
deep crawling maggots may be carefully removed 
by irrigating the wound with saline or sterile water 
(Jones & Wall, 2007; Dar et al., 2013). Maggot and 
dressings are disposed of as clinical waste (Lepage 
et al., 2012). 
 
In clinical studies, the length of time each 
application of maggots is left in the wound varies (Tab. 4). It has been suggested that as maggots 
become less active after 48 hours, they are less useful in the wound and should be removed after 
Patients Cycles Reference 
Species, number Length, 
days 
Author(s), year 
Humans, 13 4 Bowling et al., 
2007 
Humans, 70 2-3 Courtenay et al., 
2000 
Rabbits, 3 3-6 Kočišová et al., 
2003 
Equids (horses, ponies, 
donkeys), 41 (35, 2, 4) 
3 Lepage et al., 
2012 
Horses, 13 5-7 Morrison, 2010 
 
Horses, 13 2-3 Sherman et al., 
2007a 
Small animals (dogs, 
cats, rabbit) 7 (2, 3, 1) 
2-3 Sherman et al., 
2007b 
Humans, 101 3-4 Steenvoorde et 
al., 2007 
Humans, 74 1-3 Wolff & 
Hansson, 2003 
Humans, 30 1-4 Wollina et al., 
2002 
Figure 4: attaching 
an absorbent 
dressing to the 
hydrocolloid frame 
Illustration: 
Berglund, C., 2013 
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two days (Paul et al. 2009). On the other hand, maggots have been shown to metabolise a 
significantly higher mass of tissue after four days than after three, why it should be attempted to 
leave maggots in the wound for at least four days (Blake et al., 2007).  
 
After removal of maggots, the wound is reassessed to determine whether further larval therapy is 
required or not (Dar et al., 2013). The effects of cycle length and frequency of dressing changes 
need to be assessed throughout treatment (O'Dwyer, 2012). It is important to keep accurate records 
of dressing changes for management to be consistent; including condition of dressing, materials 
used (Chivers, 2010), pain score on removal of dressings (O'Dwyer, 2012) and method of analgesia 
or sedation (Chivers, 2010). 
 
If the wound deteriorates (Ramundo & Wells, 2000), if there is no sign of improvement within 10 
days of treatment or if the patients’ status changes for the worse, the treatment may need to be 
reconsidered (EWMA, 2006). 
 
Length of treatment 
Maggots are applied in cycles until    Table 5: Number of maggot cycles applied and length of treatment 
complete debridement is achieved 
(Morrison, 2007; Steenvoorde et al., 
2007; Dar et al., 2013), granulation 
tissue is observed and there are no signs 
of infection (Dar et al., 2013). 
Treatment time and number of 
applications needed until wounds were 
fully debrided differ in clinical studies 
(Tab. 5). In deep visually inaccessible 
wounds, such as puncture wounds of 
the hoof, therapy can proceed until the 
patient walks soundly for a week 
(Morrison, 2007).  
 
After therapy is discontinued, the 
wound should be managed using moist 
wound healing, according to local 
protocol (EWMA, 2006). 
 
 
Veterinary nursing aspects 
The wound and surrounding tissues will require continuous reassessment throughout the wound 
management process (EWMA, 2006; O'Dwyer, 2012). The wound must be closely monitored to 
ensure that debridement proceeds as expected (Ramundo & Wells, 2000). Detailed accurate records 
should be kept at every dressing change, so reassessment can be made by different members of staff 
if necessary (O'Dwyer, 2012). Records need to describe the wound dimensions, appearance, exudate 
(Ramundo & Wells, 2000; O'Dwyer, 2012) and odour, as well as condition of the surrounding skin 
(Ramundo & Wells, 2000) and general health of the patient (O'Dwyer, 2012). An increase in wound 
size can be observed as necrotic tissue is removed, which should not be interpreted as treatment 
failure (Ramundo & Wells, 2000). Photographs can be taken to make changes in the wound more 
easily identifiable and to encourage owners by showing them progression of wound healing 
(Chivers, 2010). The patient needs to be closely monitored for signs of spreading or systemic 
infection (EWMA, 2006). 
Patients Applications Length of 
treatment 
Reference 
Species, number Average 
(range), 
number 
Average 
(range), 
days 
Author(s), year 
Humans, 13 3 (n/a) 19 (7-45) Bowling et al., 
2007 
Humans, 70 3 (n/a) n/a Courtenay et al., 
2000 
Rabbits, 3 1,3 (1-2) n/a Kočišová et al., 
2003 
Equids (horses, ponies, 
donkeys), 41 (35, 2, 4) 
1,1 (1-2) n/a Lepage et al., 
2012 
Horses, 13 9 (1-20) n/a Sherman et al., 
2007a 
Small animals (dogs, 
cats, rabbit) 7 (2, 3, 1) 
2,1 (1-5) n/a Sherman et al., 
2007b 
Humans, 16 7 (3-21) 27 (12-83) Steenvoorde & 
Jukema, 2004 
Humans, 101 2,4 (1-11) 7 (n/a) Steenvoorde et 
al., 2007 
Humans, 74 1,4 (1-4) 7 (n/a) Wolff & 
Hansson, 2003 
Humans, 30 1,1 (1-2) n/a Wollina et al., 
2002 
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Management of wounds can be painful and prolonged (Chivers, 2010). The pain can originate from 
the wound, but also from the choice of debridement (Ramundo & Wells, 2000). Pain can cause 
animals to interfere with dressings and cause further damage to the wound (Chivers, 2010). Signs of 
discomfort such as change in behaviour should be recognised so pain can be relieved rapidly by 
administering analgesia or removing maggots (Jones & Wall, 2007). Daily analgesia may be 
indicated throughout treatment for adequate pain management (Chivers, 2010). Pain can be reduced 
by ensuring the hydrocolloid dressings are protecting the margins of the wound sufficiently, as 
eroded wound margins may be a cause of pain, or by stabilising the wounded area (Ramundo & 
Wells, 2000). On dressing changes, additional analgesia is required (Ramundo & Wells, 2000; 
Chivers, 2010). Ideally, the analgesic is administered, and dressing change timed to when the peak 
effect occurs (Ramundo & Wells, 2000). Dressing changes can be very stressful to the patient, and it 
may be necessary to anaesthetise the patient (Chivers, 2010). 
 
 
Discussion 
 
Larval therapy is rare in veterinary wound care. No prospective randomised case controlled trials on 
LT in companion animals have been performed. The studies currently available by Sherman et al. 
(2007a; 2007b) and Lepage et al. (2012) are retrospective surveys. They are neither prospective nor 
controlled, and should not be interpreted as such. The study on rabbits by Kočišová et al. (2003) is 
prospective, but there is no comparison to conventional therapy, and it involves only three animals, 
limiting the significance of the results. The Morrison (2007) study involves a greater number of 
patients, but it is not case controlled. Still, the studies represent examples of current use in 
companion animals, and if nothing else they serve to evoke interest in the LT as a treatment option. 
 
While studies on LT in humans generally are of better quality, they often lack a placebo group or 
comparison to conventional treatment, making the actual effectiveness of treatment hard to assess. 
It is often studied on patients where all other treatments have failed, which may lead to LT 
appearing superior to conventional methods of debridement, without actual evidence of that being 
the case. There are a few studies comparing LT to conventional treatments though. In two studies by 
Sherman (2002; 2003) LT was found to be more effective in debridement and promoted faster 
wound healing than the control group in treating non-healing ulcers. In the 2002 study, 92 patients 
were included. Complete debridement was shown by 80% of LT patients and 48% of controls 
within 5 weeks. Average wound reduction was 84% in LT wounds and 37% in the control group. In 
the 2003 study, 18 patients were treated. After 4 weeks LT wounds were completely debrided, and 
conventionally treated wounds were still covered in an average of 37% necrotic tissue. Granulation 
tissue covered an average of 56% of the test group wounds, and 15% of the control group. A third 
study by Paul et al. (2009) showed no significant difference in the wound outcome of the different 
treatments in 54 patients with diabetic foot ulcers, however patients receiving LT were hospitalised 
for a significantly shorter length of time. 
 
There are some issues to consider before using larval therapy on canine, feline or equine patients. 
Appropriate number of maggots per cm², for example, must be researched before initiating 
treatment on small animal patients. Sherman et al. (2007b) and Jones & Wall (2007) state that 
maggot therapy can theoretically cause the same adverse effects as myiasis, maggot infestation in 
nature. Myiasis can cause ammonia toxicity affecting the kidneys and heart, according to Jones & 
Wall (2007), with potentially fatal consequences. Dogs suffering from myiasis can present 
symptoms such as depression, anorexia and pyrexia, as noted by Orfanou et al. (2011). Some dogs 
also exhibited lameness due to local pain caused by maggots infesting limb wounds. Additional 
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symptoms, from observations in sheep by Elkington et al. (2009), include tachycardia and 
tachypnoea. As Jones & Wall (2007) describe the condition as associated with a large number of 
maggots, the patients’ size relative to the size of the wound is a risk factor for iatrogenic ammonia 
toxicity. The standard dose of 5-10 maggots/cm² may be unsuitable for a small animal with a large 
wound. Small animals in general should be treated with caution and monitored more closely during 
treatment. Further studies are required to be able to more exactly calculate a safe number of 
maggots for treatment on small animals. 
 
Another aspect relating to the different species in veterinary wound care is the differences in wound 
healing. These differences have been described by Bohling & Henderson (2006). Cats’ wounds heal 
slower than dogs’; contraction and epithelisation are slower, as well as production of granulation 
tissue. Granulation has been completed 2, 5 times faster in dogs than in cats in identically created 
wounds. In dogs granulation tissue appears simultaneously from the entire wound surface, whereas 
in cats it originates from the wound edges and advances towards the middle. Feline wound breaking 
strength is also significantly lower: after a week of healing only half of that in dogs. Bohling & 
Henderson (2006) also recount the differences in wound healing between horses and ponies. Horses 
have a tendency for persisting inflammation due to a weak inflammatory response. It often leads to 
excess amounts of granulation tissue, especially on the distal limbs, resulting in chronic non-healing 
wounds. Ponies have a stronger inflammatory response, which normally leads to wound healing 
progressing with fewer complications than in horses. The physiology of wound repair in different 
species is important to remember in any wound care situation, especially when problems with 
treatment arise. However, the importance of these findings to the use of larval therapy in companion 
animals is yet uncertain. 
 
A considerable problem in treating animals according to Sherman et al. (2007b) is applying the 
dressing in a way that stops the animal from removing it. In conventional wound dressings, the 
secondary layer consists of soft orthopaedic wool to hold the primary layer in position and ensure 
even pressure across the dressing, as described by Chivers (2010). This is covered by gauze. A 
tertiary layer, typically consisting of a self-adherent elastic dressing, is added to protect the 
underlying layers from soaking and soiling according to Chivers (2010). The maggots’ need of 
oxygen however, may limit the possibilities of using these additional dressing layers. They could 
also prove to apply too much pressure, effectively killing the maggots. If the wound is located to a 
lower limb, a waterproof sock or boot can be used for outside exercise to protect the underlying 
layers. This will not solve the problem of dressings not staying in place though. Moreover, any 
supporting layers used must be uncomplicated to change, as the owner will need to be able to 
perform this at home due to the heavy exudation of LT wounds. No mention of this has been made 
in literature, possibly due to the fact that secondary and tertiary layers are not as important in laying 
lasting dressings in human wound care.  
 
Dressings' not keeping in place is not the only challenge in dressing maggot wounds. Dressings are 
elaborate and typically difficult to apply. Dressing changes are carried out in two parts. The 
maggots are removed and the wound evaluated. If further therapy is needed, Sherman (2002; 2003) 
recommends covering the wound with saline-moistened gauze while waiting for the next batch to 
arrive and maggots can be reapplied. As maggots and dressings are removed, the first visit is likely 
to involve more pain. The second visit, though less painful, requires a certain composure of the 
patient as reapplication of dressings and maggots is rather intricate. Depending on personality of the 
patient, sedation or general anaesthesia may be required at either dressing change. Only experience 
or further studies can help to ascertain whether sedation or anaesthesia will be required to a greater 
extent with LT than with other treatment methods. 
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Larval therapy appears to be the most effective of the non-surgical debridement options according 
to Sherman (2002). Steenvoorde et al. (2007) found that ASA classification of the human patient is 
not a factor that influences outcome of LT. This opens up possibilities for treating animals too ill or 
too high risk for anaesthesia, providing methods for dressing applications can be developed enough 
to perform dressing changes while the patient is awake.  
 
The study by Steenvoorde et al. (2007) also showed that location or size of the wound does not 
influence outcome. Factors that did have a negative impact on outcome of LT in the study included 
older age of the patient, wound duration over three months, non-traumatic origin of wound, septic 
arthritis and deep wounds with visible tendon, muscle or bone. The cost of therapy is always a 
concern in veterinary medicine, and choosing patients likely to have a successful outcome of the 
treatment will enable a more economical use of the owners’ resources.  
 
It has been suggested by Sherman et al. (2007b) that LT is less expensive than surgery or prolonged 
antibiotic treatment. A randomised controlled trial measuring cost effectiveness of maggot therapy 
compared to autolytic debridement using hydrogel dressings has been conducted by Wayman et al. 
(2010). It was found that cost of LT per patient was 42% less than conventional therapy in human 
medicine. In dogs, cats and horses though, considering the possible need for sedation or anaesthesia 
and the added cost accompanying frequent hospital visits for dressing removal and application, it is 
unlikely that the cost effectiveness in human wound care will be reflected in companion animals. 
  
The possible development of wound care products using larval ES has been investigated to utilise 
the positive properties of secretions without using actual maggots in wounds. After treating larval 
ES with heat in the study by Horobin et al. (2003), the secretions were still active, albeit 
significantly less active than before. Kerridge et al. (2005) found that larval secretory products 
could endure lyophilisation (freeze-drying) and long term storage at various temperatures. The 
products proved to be only slightly less active against MRSA after four months of storage at 4°. 
While a wound dressing with maggot secretions cannot replace the ingestion of bacteria and 
necrotic tissue performed by the maggots, it will be much more user friendly and may prove to be a 
good alternative to LT in the future. 
 
There are scarcely any nursing studies on human patients receiving larval therapy, and certainly 
none on animal patients. There are several veterinary nursing aspects of larval therapy that 
necessitates further investigation, but as LT is a rare treatment form and a veterinary nursing is a 
new science, studies have yet to be undertaken. 
 
One nursing specific aspect in humans is concerning patient perception of treatment. Acceptability 
is considered a problem both by patients and practitioners. However, in the previously mentioned 
studies by Petherick et al. (2006) and Spilsbury et al. (2008), no extensive aversion to the use of 
maggots was found. Similar results were found by Steenvoorde et al. (2005). None of the patients 
(n=37) refused LT, and 89% were willing to undergo treatment again. Even if humans are not the 
ones receiving treatment in the veterinary field, problems with containment of maggots may still be 
an issue that negatively influences the acceptance of LT. In the study by Steenvoorde et al. (2005), 
maggots escaped the wound of 43% of the patients at some point during treatment. The escape rate 
was 12% for all free range applications. As dogs and cats typically live indoors, the owner may be 
deterred by the idea of escaping larvae. Owner acceptability is probably less of a problem with use 
of LT in horses due to the difference in living environments. Regardless of patient, any potential 
acceptability issues will hopefully be resolved by open communication with the owner. The 
veterinary nurse is likely the one to help the owner understand the treatment procedure. 
 
19 
Pain evaluation and management is an important nursing aspect. The most commonly mentioned 
adverse effect in human patients is pain, and in animals patients it is discomfort. As no pain scores 
were used during the veterinary studies, it is plausible to believe that these are in fact one and the 
same. Discomfort can be caused by irritation or itching, but it can also mean that the patient is 
experiencing pain, a fact which should not be overlooked. Pain evaluation is important when 
treating wounds with maggots, but not only to keep the patient pain free. In the studies by 
Courtenay et al. (2000) and Wolff & Hansson (2003) patients actually experienced less pain than 
prior to treatment, which may lead to unnecessary medication if analgesia is given without 
assessment. 
 
Nursing models can be used to identify and attend to veterinary nursing related problems in larval 
therapy. Bale & Jones (2006) describe nursing models as aids to relate nursing theory to clinical 
practice. The nursing role of care is emphasised, rather than the medical, and the patients' needs are 
central in the decision making process. A simple care plan based on problem, goal and intervention 
can be implemented to ease management of LT. A care plan is patient specific, and problems can be 
marked as potential or actual. For instance, a problem can be dressings not staying in place. The 
goal is then to minimise disturbance of dressings, and intervention can be to evaluate pain and 
analgesia, and to check owner compliance of use of Elizabethan collar. Another potential problem is 
owner experiencing maggot-related anxiety. The goal is to reduce anxiety to allow treatment to 
proceed. This can be achieved by allowing the owners to communicate their anxieties, by 
discouraging owners from being present at dressing changes, or by minimising risk of maggots 
escaping by appropriate wound dressings. 
 
 
Conclusion 
Despite the lack of material, the chosen method of a literature study was successful in achieving the 
objective of this student report. While it would be interesting to learn to which extent LT is used in 
companion animals in Sweden, if at all, the unusualness of the treatment makes a survey difficult to 
perform. Based on the knowledge obtained by engaging in this project, some experimental studies 
could be performed within the limits of an undergraduate project. For instance, investigating if any 
of the dressing materials commonly used in companion animals are compatible with larval therapy, 
with focus on larval survival in the wound. However, the need for potential experiments such as this 
one would not have been recognised without the foundation laid by this literature study.  
 
How LT in companion animal wound care compares to conventional therapies remains to be seen. 
As LT can be used to successfully treat MRSA, it is definitely a treatment option that deserves more 
attention. One of the most commonly mentioned disadvantages in human wound care is patient 
acceptability. While owners' perceptions of the therapy potentially present a problem, the patient 
itself is unlikely to suffer from maggot-related anxiety. The disadvantage of more frequent dressing 
changes in the hospital setting must be weighed against the possibility of restoring the animal to 
health faster, and thus shortening the total length of treatment. Maggot wounds are difficult to dress, 
and the patients may require anaesthesia or sedation to a greater extent than in conventional wound 
dressings, although this is so far only speculation. The dressing changes are likely to be easier with 
growing experience of the veterinary nurse. If dressing changes could be performed without 
anaesthesia, this would be a major advantage, as the therapy appears to be effective with patients 
too ill for surgery.  
 
Further clinical studies are needed, not only to ensure the safety and efficiency of the treatment, but 
also to increase awareness and encourage more veterinary nurses and physicians to take the first 
steps towards using larval therapy in our dogs, cats and horses. 
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Populärvetenskaplig sammanfattning (popular science summary) 
 
Att fluglarver kan användas för att behandla sår med infektion eller död vävnad har varit känt sedan 
länge. Sårvård med fluglarver var vanligt under 1940-talet, men när antibiotikan introducerades 
avtog behandlingens popularitet. När antibiotikaresistens började spridas väcktes intresse för 
larvterapi igen, nu med förbättrade metoder med sterila larver. 
 
Larverna som används är från guldflugan Lucilia sericata, en typ av spyfluga som är vanligt 
förekommande i Europa. Larver från guldflugan är lämpliga eftersom de bara livnär sig på död 
vävnad, och de äter ytligt. Dessutom lägger guldflugan ägg, vilket gör steriliseringsprocessen 
lättare. Sterila larver beställs från ett laboratorium. 
 
Larver avlägsnar effektivt död vävnad och bakterier, och påskyndar dessutom sårläkningsprocessen. 
Hos människor används larver framförallt för att behandla sår som inte läker med konventionella 
metoder, såsom liggsår och fotsår orsakade av diabetes. Användning hos våra sällskapsdjur är 
fortfarande ovanlig. Det finns exempel på larvterapi hos hundar och katter för att behandla trycksår 
och traumatiska sår som riv- och bitsår. Hos häst förefaller behandlingen vanligare, då används 
larver främst för att behandla sjukdomstillstånd i hoven såsom fång eller djupa sticksår. Larvterapi 
är också effektivt mot sår infekterade med resistenta bakterier som MRSA. 
 
Smärta i samband med terapi är förhållandevis vanligt, varför en viktig omvårdnadsaspekt är att 
identifiera och förebygga smärta. Övriga biverkningar är få och milda.  
 
Vid leverans är larverna ungefär en dag gamla och 3 mm långa. Larverna kan placeras direkt i såret, 
eller indirekt i en påse gjord av finmaskigt nät, en så kallad biopåse. Förutsatt att inga biverkningar 
uppträder kan larverna vara kvar i såret i runt fyra dagar. Då är de fullvuxna, ungefär 10 mm långa. 
I naturen skulle larverna lämna såret i det här skedet för att bli puppor. Det är väldigt osannolikt att 
detta skulle hända i såret. Avlägsnade larver hanteras som kliniskt avfall. Efter utvärdering av såret 
kan en ny omgång påbörjas; larver appliceras i cykler tills det inte finns någon infektion eller död 
vävnad kvar. Efter avslutad behandling återupptas konventionell sårvård med fokus på sårläkning. 
 
Bandagen som används i larvterapi består av flera delar som tillsammans skyddar omkringliggande 
hud från sårvätska och larvernas sekretioner, håller larverna instängda och absorberar sårvätska 
samtidigt som larverna får tillgång till syre. Det är inte lätt att lägga förband för larvterapi, och en 
utmaning för djursjukskötaren kommer att vara att få förbanden att hållas på plats. 
 
Ett möjligt problem är att djurägaren känner obehag för larverna. Information från djursjukskötaren 
om terapin kommer troligen att vara en viktig del i djurägarens acceptans av behandlingen.  
 
Fler studier krävs inom larvterapi för våra sällskapsdjur. Vilken mängd larver som är både säker och 
effektiv att använda för smådjur behöver undersökas. Hur olika bandagematerial påverkar larvernas 
syretillförsel är också viktigt att ta reda på, för att underlätta bandageläggning och minska 
kostnaden för misslyckad behandling för djurägaren. Kliniska studier kommer också att öka 
medvetenheten om behandlingen bland djursjukskötare och veterinärer, vilket förhoppningsvis leder 
till att larvterapi börjar användas i större utsträckning. 
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